Birth Control and HS: Can Contraception Affect Hidradenitis Suppurativa? Canonical URL: https://www.acneinversa.life/en/blog/hs-contraception-birth-control/ Markdown URL: https://www.acneinversa.life/en/blog/hs-contraception-birth-control.md Plain text URL: https://www.acneinversa.life/en/blog/hs-contraception-birth-control.txt Language: en Category: Treatments Published: 2026-08-21 Last updated: 2026-08-21 Last editorially reviewed: 2026-08-21 Next scheduled review: 2027-08-21 Evidence strength: Limited evidence — Rests mainly on case series, preliminary studies, or expert consensus. Author: Dr. rer. nat. Dennis Alexander Kwiatkowski (Biochemist, Scientific Writer and Pharma Expert) Scientific editor: Dr. rer. nat. Dennis Alexander Kwiatkowski Reviewer qualifications: Biochemist, Scientific Writer and Pharma Expert Review scope: Scientific literature, clinical guidelines, sources, and editorial clarity Clinical reviewer: No independent clinical review Tags: Acne Inversa, Hidradenitis Suppurativa, HS, Treatments, contraception, birth control, hormonal contraception, progestogen, rifampicin, spironolactone, reproductive health, treatment decisions Contraception is a medical decision in its own right. Here is what the evidence actually shows about hormonal methods and HS, a method-by-method comparison, and the rifampicin interaction worth knowing before you decide. Medical disclaimer: This website is for general educational information only and does not replace medical advice, diagnosis, or treatment. Please speak with qualified medical professionals about symptoms or treatment decisions. 60-second summary - Small observational studies suggest combined estrogen-progestogen contraception is associated with better HS control than progestogen-only methods, but this cannot predict an individual response. - Which contraceptive methods are medically appropriate for you depends on far more than HS — age, smoking, clotting risk, and migraine decide that first. - Evidence on hormonal IUDs, implants, and injections specifically in HS is very sparse. - Rifampicin, sometimes used for HS, can reduce the effectiveness of several hormonal contraceptives — this needs a proactive conversation, not a guess. - Non-hormonal contraception does not treat HS, but that does not make it the wrong choice if it otherwise suits you well. What this means: Contraceptive safety, reliability and your own preferences come first. Any possible effect on HS is a secondary consideration, not a reason to accept a method that does not otherwise suit you. What we are less certain about: The comparative studies are retrospective or small, non-randomized, and cannot separate cause from the reasons people were prescribed one method rather than another. What you can do next: If you take rifampicin, or are starting it, tell whoever manages your contraception so your method can be reviewed. Article Hormones appear to influence hidradenitis suppurativa in at least some people. That is part of why HS can change around the menstrual cycle, during pregnancy, or around menopause, and why certain hormonal treatments are sometimes used as part of HS management. But choosing contraception is not the same decision as choosing an HS treatment. If you need contraception, the questions that matter most are: does it prevent pregnancy reliably enough for your needs, is it medically appropriate for you, and does it fit your preferences and plans? Only after those should you ask whether it might also affect your HS. Educational content only. This article summarizes what limited research suggests about contraception and HS. It cannot tell you which method is medically appropriate for you, and it is not a substitute for a contraceptive-eligibility assessment with a qualified clinician. Key takeaways - Current evidence suggests some hormonal contraceptive methods may affect HS activity, but the studies are small, observational, and cannot predict an individual's response. - One retrospective cohort found combined estrogen–progestogen contraception associated with more stable or improved HS than progestogen-only contraception — an association, not proof of causation. - Contraceptive medical eligibility (clotting risk, migraine, smoking, cardiovascular history, and more) determines whether a method is appropriate for you well before any possible HS effect does. - Evidence specific to hormonal IUDs, implants, and injections in HS is too sparse to support any general recommendation for or against them. - Rifampicin, used in some HS antibiotic regimens, can reduce the effectiveness of several hormonal contraceptives — this is the single most actionable point in this article. - Non-hormonal methods do not treat HS, but they are not automatically the "safer" choice either — each method has its own trade-offs unrelated to HS. Why might contraception affect HS? HS is an inflammatory disease centered on the hair follicle, and sex hormones appear to play some role in its activity for at least some people — plausible from the disease's usual onset after puberty, its tendency to change during pregnancy, and the antiandrogenic treatments sometimes used for it. Researchers still do not fully understand the mechanism. Hormonal contraceptives alter estrogen and/or progestogen signaling, and some progestogens have more androgenic activity than others. That creates a biologically plausible reason different hormonal contraceptives might affect HS differently. Plausibility is not the same as proof. It is not enough, on its own, to tell you which contraceptive will affect your HS, or whether it will affect it at all. What do the comparative studies actually show? Two studies form most of the direct evidence connecting contraceptive method to HS activity, and both are worth reading carefully rather than by headline. | Study | Design | Finding | | Huang et al., 2024 | Retrospective cohort, 160 adults with HS using hormonal contraception | Combined estrogen–progestogen users were more likely to have stable/improved HS than progestogen-only users (adjusted OR 3.14, 95% CI 1.18–8.35) | | Montero-Vilchez et al., 2021 | Prospective observational, 100 participants (50 starting oral contraceptives, 50 controls) | Mean reduction in inflammatory nodules/abscesses at 12 weeks: 53.9% (oral-contraceptive group) vs. 38.42% (control group) | Neither study randomly assigned participants to a contraceptive method. That matters because whatever led someone to be prescribed combined contraception rather than a progestogen-only method — clinical history, other conditions, physician preference — can also independently relate to their HS course. Both studies also allowed other concurrent HS treatments, which makes isolating the contraceptive's own effect harder. The defensible conclusion is: combined hormonal contraception was associated with better HS control in these studies. Not: combined hormonal contraception is proven to improve HS, or is three times more effective than progestogen-only methods for everyone. The European S2k HS guideline and North American HS management guidelines both discuss hormonal therapy along similar lines — some antiandrogenic, estrogen-containing regimens may help selected patients, while some progestogens have been anecdotally linked to worsening — and both guidelines describe this evidence base as limited. Contraceptive safety comes before any possible HS effect Whether estrogen-containing contraception is appropriate for you depends on far more than HS. Current international contraceptive-eligibility guidance weighs factors such as age, smoking, history or risk of blood clots, cardiovascular disease, blood pressure, migraine with aura, postpartum or breastfeeding status, other health conditions, and interacting medicines. A possible HS benefit never overrides a medical reason not to use estrogen-containing contraception. If combined contraception is not appropriate for you, that is not a reason to accept a method that feels unsafe or unsuitable — it is a reason to look at the other medically appropriate options. A practical, honest method-by-method summary None of these entries is a ranking. Ordering methods by HS evidence quality would suggest a precision the research doesn't have. Combined estrogen–progestogen contraception (pill, patch, ring). HS evidence: limited, but relatively favorable in observational comparisons with progestogen-only methods. Main caution: not medically appropriate for everyone — clotting risk, migraine with aura, and smoking history can rule it out regardless of HS. Worth raising with a clinician particularly where HS shows a clear menstrual pattern, but only among options that are otherwise suitable for you. Progestogen-only pill. HS evidence: limited; some studies and guidelines note a concern about worsening, largely from the same comparative data above. Main caution: this should not be generalized into "progestogen-only contraception is harmful" — different progestogens have different properties, and people prescribed this method often differ from combined-contraception users in ways that affect the comparison. If medically preferred or necessary for you, HS alone is not a reason to reject it. Hormonal IUD. HS evidence: very limited. Some older literature and patient resources report anecdotal worsening with progestogen-containing methods including hormonal IUDs, but this falls well short of evidence that would justify a general recommendation to avoid them. If you already use one and your HS is stable, there is no evidence-based reason to remove it for HS alone. Contraceptive implant. HS evidence: very limited, direct data essentially absent. Extrapolating from oral-contraceptive studies to an implant is scientifically weak given different hormone exposure. Choose primarily on contraceptive grounds; note and discuss any change in HS afterward rather than assuming a cause. Contraceptive injection. HS evidence: very limited. As with the implant, there is no robust HS-specific recommendation — use standard contraceptive counseling (effectiveness, side effects, duration) to decide. Copper IUD. HS evidence: no plausible direct hormonal effect, since it contains no hormones. Main consideration: can increase menstrual bleeding, which is relevant if you already experience heavy periods or iron deficiency. A valid non-hormonal option where otherwise appropriate — not an HS treatment. Condoms and other barrier methods. HS evidence: no direct disease-modifying mechanism, hormonal or otherwise. Condoms are also the only contraceptive method that additionally reduces the risk of sexually transmitted infection transmission — relevant on its own terms, separate from HS. For HS affecting the groin or genital area, comfort during active flares is a practical, not a disease-treatment, consideration. The interaction that matters most: rifampicin If one detail from this article is worth remembering, make it this one. Rifampicin (also called rifampin) is used in some antibiotic regimens for HS. It strongly induces drug-metabolizing enzymes, which can lower blood concentrations of contraceptive hormones and reduce the effectiveness of several hormonal contraceptive methods. What to do: if you are prescribed rifampicin, tell whoever manages your contraception and ask whether your current method remains reliable or whether an additional or alternative method is needed while you take it. The right approach depends on your specific contraceptive method, so this is a conversation to have rather than something to work out from this page alone. This is a question about pregnancy prevention, not about whether rifampicin itself changes HS hormone biology — those are separate issues. A note on other antibiotics: do not assume every HS antibiotic behaves the same way. Rifampicin's effect comes from its unusually strong enzyme-inducing action. Ask specifically about interactions for whatever you are prescribed rather than generalizing from this one drug. Spironolactone and pregnancy prevention Spironolactone is an antiandrogenic medication sometimes used off-label for HS, often for people with a clear menstrual pattern, hirsutism, or PCOS features. It is not recommended during pregnancy because of concern about antiandrogenic effects on fetal development. If pregnancy is possible while you take spironolactone, it is worth discussing a pregnancy-prevention approach with the clinician who prescribes it. This does not mean everyone taking spironolactone needs a combined oral contraceptive specifically — the appropriate method still depends on you. If my HS changed after starting or stopping a method HS fluctuates on its own, so a single flare after starting a contraceptive is not proof of cause. A more useful approach is reconstructing the timeline: - When did you start (or stop) the method? - What was your HS like in the three months before? - Did lesion count or affected body areas change? - Did any other HS treatment change around the same time? - Did stress, smoking, weight, or another factor change too? - Has the pattern persisted, or was it a one-off? If the relationship seems repeatable and substantial in either direction — worse or better — that is useful information to bring to an appointment, alongside your medical eligibility, contraceptive goals, and side-effect tolerance. It is not, on its own, grounds to change a method that is otherwise working well for you. Questions to take to your appointment 1. Which contraceptive methods are medically suitable for me before we even factor in HS? 2. My HS clearly changes around my menstrual cycle — does that shift which suitable methods are worth discussing? 3. Is the evidence about progestogen-only contraception strong enough to matter for my situation specifically? 4. Could any of my HS medicines reduce my contraceptive effectiveness? 5. If I'm prescribed rifampicin, what do I need to change, and for how long? 6. If I take spironolactone, what pregnancy-prevention approach makes sense? 7. If my HS changes after starting a new method, how long should we watch the pattern before deciding it matters? 8. What would change about this if I'm planning pregnancy in the next year or two? What the evidence does not show It does not show that combined pills improve HS in everyone, that progestogen-only contraception worsens HS in everyone, that hormonal IUDs should be routinely removed in people with HS, that copper IUDs are inherently better for HS, that contraception can replace appropriate HS treatment, or that one contraceptive formulation is the best HS option for all patients. That uncertainty is part of an honest decision, not something to smooth over. The bottom line Contraception and HS overlap, but they are not the same decision. Current observational evidence suggests a potentially more favorable HS pattern with combined estrogen–progestogen contraception than with progestogen-only contraception — but it is too limited to function as a universal prescribing rule. Work through it in this order: medical safety and eligibility first, contraceptive effectiveness and your own preferences second, possible HS effects third. And if rifampicin is part of your HS treatment, raise contraception explicitly — it can reduce the effectiveness of several hormonal methods, and that is worth catching before it matters rather than after. FAQ Can birth-control pills improve hidradenitis suppurativa? Possibly, in some people. Small observational studies and current HS treatment guidelines list estrogen-containing combined oral contraceptives among the hormonal options considered for appropriately selected patients, particularly where flares track the menstrual cycle. The evidence is not strong enough to predict an individual response, and it does not make combined contraception the right choice for everyone. Can birth control make HS worse? Some people report worsening, and observational research raises a specific concern about progestogen-only contraception being associated with poorer HS control compared with combined methods. This has not been shown strongly enough to conclude that any one method will worsen HS in a given person — the studies are retrospective and cannot rule out other explanations. Is the combined pill the best contraception for HS? No single method is best for everyone. Combined hormonal contraception may be associated with more favorable HS patterns in some observational data, but it is not medically appropriate for every person — factors such as clotting risk, migraine with aura, and smoking can rule it out regardless of HS. Does the mini-pill or another progestogen-only method worsen HS? Limited evidence, including one retrospective cohort, suggests poorer disease control among progestogen-only contraceptive users compared with combined-method users. That is an association in aggregated data, not proof that a specific progestogen-only method will worsen HS in an individual, and it should not be treated as a reason to avoid an otherwise appropriate method. Should I have my hormonal IUD removed because I have HS? There is no good evidence to support removing a well-tolerated hormonal IUD solely because of an HS diagnosis. HS-specific data on hormonal IUDs is very limited. If your HS changed substantially after insertion, document the timeline and discuss it with your clinician rather than assuming a cause. Is a copper IUD better for HS because it has no hormones? A copper IUD is not expected to influence HS through hormonal signaling, but 'non-hormonal' is not automatically 'better' — copper IUDs can increase menstrual bleeding, which is worth weighing if you already deal with heavy periods or iron deficiency. Choose based on your overall contraceptive needs, not on avoiding hormones alone. Does rifampicin affect birth control? Yes. Rifampicin is a strong enzyme inducer and can reduce the effectiveness of several hormonal contraceptive methods. If it is prescribed as part of your HS treatment, tell whoever manages your contraception so you can review whether your method is still reliable or whether an additional method is needed. Do all HS antibiotics reduce contraceptive effectiveness? No. The rifampicin interaction is unusual because of how strongly it induces drug-metabolizing enzymes. Do not assume that other antibiotics used for HS, such as doxycycline or clindamycin, have the same effect — ask specifically about any medicine you are prescribed rather than generalizing from rifampicin. Do I need to think about contraception if I am taking spironolactone? Spironolactone is not recommended during pregnancy because of concerns about its antiandrogenic effects on fetal development. If pregnancy is possible while you take it, it is worth discussing a pregnancy-prevention approach with the clinician who prescribes it — this does not mean everyone on spironolactone needs a specific contraceptive method. Can contraception replace my HS treatment? Usually not, especially in moderate-to-severe or actively progressing disease. Hormonal contraception can be one component of a broader HS treatment plan in selected patients, but it does not reverse established tunnels or scarring and should not be used to delay treatments known to control active inflammation. References 1. Huang CY, Lee YW, et al. Hidradenitis suppurativa disease control associated with type of hormonal contraceptive use: a retrospective cohort study. - Clinical and Experimental Dermatology, 2024;49(4):375–378 2. Montero-Vilchez T, Diaz-Calvillo P, et al. The Role of Oral Contraceptive Pills in Hidradenitis Suppurativa: A Cohort Study. - Life (Basel), 2021;11:697 3. Molinelli E, et al. The influence of hormonal combined contraceptive in the onset of hidradenitis suppurativa: a retrospective cohort study. - Clinical and Experimental Dermatology, 2025;50(5):1002–1005 4. Zouboulis CC, et al. European S2k guidelines for the treatment of hidradenitis suppurativa/acne inversa, part 2: treatment. - Journal of the European Academy of Dermatology and Venereology, 2025 5. Alikhan A, et al. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations, Part II. - Journal of the American Academy of Dermatology, 2019 6. American Academy of Dermatology. Hidradenitis suppurativa: Diagnosis and treatment. - AAD patient information 7. World Health Organization. Medical Eligibility Criteria for Contraceptive Use, sixth edition. - WHO, published 3 November 2025 8. World Health Organization. Selected Practice Recommendations for Contraceptive Use, fourth edition. - WHO, published 3 November 2025 9. World Health Organization. Guidance on drug interactions between rifamycins and hormonal contraceptives (TB treatment guidance). - WHO 10. Ghanshani R, et al. A Guide to the Management of Hidradenitis Suppurativa in Pregnancy and Lactation. - American Journal of Clinical Dermatology, 2025